| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.74▼ | 0.74▼ | 0.74▼ | 0.76▼ | 0.80▼ |
| MA10 | 0.74▼ | 0.75▼ | 0.75▼ | 0.81▼ | 0.80▼ |
| MA20 | 0.75▼ | 0.75▼ | 0.76▼ | 0.83▼ | 0.97▼ |
| MA50 | 0.76▼ | 0.79▼ | 0.83▼ | 0.81▼ | 1.33▼ |
| MA100 | 0.79▼ | 0.83▼ | 0.82▼ | 1.03▼ | 2.52▼ |
| MA200 | 0.83▼ | 0.83▼ | 0.81▼ | 1.26▼ | 23.95▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.002▲ | 0.003▲ | -0.014▼ | 0.018▲ |
| RSI | 41.438▼ | 35.350▼ | 33.320▼ | 38.284▼ | 37.388▼ |
| STOCH | 61.476 | 36.353 | 30.778 | 5.313▼ | 31.514 |
| WILL %R | -65.152 | -74.349 | -86.200▼ | -96.634▼ | -75.182▼ |
| CCI | -83.050 | -78.040 | -70.833 | -130.928▼ | -136.738▼ |
|
Sunday, November 09, 2025 11:31 PM
In July 2025, the FDA approved Longeveron’s Investigational New Drug (IND) application for its stem cell therapy laromestrocel as a potential treatment for pediatric dilated cardiomyopathy (DCM). The ...
|
|
Sunday, November 09, 2025 11:13 PM
In a report released yesterday, Boobalan Pachaiyappan from Roth MKM reiterated a Buy rating on Longeveron, with a price target of $3.00. The company’s shares closed yesterday at $0.80.
|
|
Thursday, November 06, 2025 04:17 AM
Operator: Greetings, and welcome to the Longeveron 2025 Q3 Financial Results and Business Update Call. [Operator Instructions] As a reminder, this conference is being recorded.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/11/25 | 0.7548 | 0.7548 | 0.735 | 0.7419 | 125,998 |
| 07/11/25 | 0.763 | 0.784 | 0.737 | 0.737 | 334,000 |
| 06/11/25 | 0.7744 | 0.7969 | 0.7625 | 0.77 | 251,292 |
| 05/11/25 | 0.80 | 0.8036 | 0.76 | 0.762 | 383,984 |
| 04/11/25 | 0.82 | 0.82 | 0.80 | 0.80 | 307,000 |
| 03/11/25 | 0.85 | 0.851 | 0.82 | 0.831 | 304,100 |
| 31/10/25 | 0.82 | 0.85 | 0.811 | 0.834 | 234,600 |
| 30/10/25 | 0.862 | 0.862 | 0.825 | 0.837 | 223,100 |
| 29/10/25 | 0.925 | 0.925 | 0.86 | 0.888 | 363,100 |
| 28/10/25 | 0.92 | 0.93 | 0.914 | 0.929 | 303,600 |
|
|
||||
|
|
||||
|
|